SONA Stock Overview
Operates as a nanotechnology life sciences company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Sona Nanotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.26 |
| 52 Week High | CA$0.56 |
| 52 Week Low | CA$0.18 |
| Beta | -1.71 |
| 11 Month Change | -1.92% |
| 3 Month Change | -7.27% |
| 1 Year Change | 37.84% |
| 33 Year Change | -31.08% |
| 5 Year Change | 96.15% |
| Change since IPO | 50.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| SONA | CA Life Sciences | CA Market | |
|---|---|---|---|
| 7D | -1.9% | 1.9% | 1.1% |
| 1Y | 37.8% | 5.5% | 22.9% |
Return vs Industry: SONA exceeded the Canadian Life Sciences industry which returned 5.5% over the past year.
Return vs Market: SONA exceeded the Canadian Market which returned 22.9% over the past year.
Price Volatility
| SONA volatility | |
|---|---|
| SONA Average Weekly Movement | 8.2% |
| Life Sciences Industry Average Movement | 9.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: SONA has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: SONA's weekly volatility has decreased from 14% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | David Regan | www.sonanano.com |
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests.
Sona Nanotech Inc. Fundamentals Summary
| SONA fundamental statistics | |
|---|---|
| Market cap | CA$27.93m |
| Earnings (TTM) | -CA$3.02m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-9.4x
P/E RatioIs SONA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SONA income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$3.02m |
| Earnings | -CA$3.02m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.027 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -501.7% |
How did SONA perform over the long term?
See historical performance and comparison